New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) shows that following treatment with GLP-1 drugs for obesity, most weight loss is fat mass (80–85%) and relative muscle mass is preserved.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗